Sara MajocchiDiscovery Program Leader at Light Chain Bioscience
Sara Majocchi is a Discovery Program Leader at Light Chain Bioscience (a brand of Novimmune SA), based in Geneva, Switzerland. She obtained her master’s degree in biotechnology from the École Supérieure de Biotechnologie de Strasbourg, Louis Pasteur University, France and her PhD in Life Science from the University of Lausanne, Switzerland. After graduation, Sara joined the Research Department of Light Chain Bioscience where her focus was on developing mouse models to support the preclinical development of the first bispecific therapeutic programs targeting CD47. Since 2018, she has been leading the discovery of therapeutic bispecific antibodies, from early discovery to clinical lead candidate selection.